Search research articles
Contact Us
Filters
Showing results (151-160 of 162) with videos related to
Page
of 17
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 6, 2024
A pooled analysis of trastuzumab deruxtecan in patients with human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer with brain metastases
F André, J Cortés, G Curigliano, et al.
Human Genetics
|
May 14, 1999
Molecular characterization of germline mutations in the BRCA1 and BRCA2 genes from breast cancer families in Taiwan
S S Li, H M Tseng, T P Yang, et al.
Annals of Medicine and Surgery (2012)
|
January 3, 2022
A prospective, multicenter trial of a long-term bioabsorbable mesh with Sepra technology in cohort of challenging laparoscopic ventral or incisional hernia repairs (ATLAS trial)
William W Hope, Adel G El-Ghazzawy, Brad A Winterstein, et al.
Interventional Neuroradiology : Journal of Peritherapeutic Neuroradiology, Surgical Procedures and Related Neurosciences
|
March 12, 2013
Taiwan aneurysm registry: multivariate analysis of two-month, one-year, and two-year outcomes after endovascular and microsurgical treatment of ruptured aneurysms
H-M Liu, H-F Wong, K-W Lee, et al.
ESMO Open
|
May 25, 2024
Trastuzumab deruxtecan versus trastuzumab emtansine in HER2-positive metastatic breast cancer patients with brain metastases from the randomized DESTINY-Breast03 trial
S A Hurvitz, S-B Kim, W-P Chung, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 21, 2026
Datopotamab deruxtecan (Dato-DXd) in combination with durvalumab as first-line treatment for unresectable locally advanced or metastatic triple-negative breast cancer: results from arms 7 and 8 of the phase Ib/II BEGONIA study
P Schmid, H-C Wang, F Lynce, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 22, 2020
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with early breast cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS
Y H Park, E Senkus-Konefka, S-A Im, et al.
Blood
|
January 14, 2022
Congenital anemia reveals distinct targeting mechanisms for master transcription factor GATA1
Leif S Ludwig, Caleb A Lareau, Erik L Bao, et al.
ESMO Open
|
May 25, 2024
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with early breast cancer
K H Park, S Loibl, J Sohn, et al.
ESMO Open
|
May 13, 2023
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, staging and treatment of patients with metastatic breast cancer
S-A Im, A Gennari, Y H Park, et al.
Page
of 17
Search research articles
Search
Showing results (151-160 of 162) with videos related to
Sort By:
Page
of 17
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 6, 2024
A pooled analysis of trastuzumab deruxtecan in patients with human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer with brain metastases
F André, J Cortés, G Curigliano, et al.
Human Genetics
|
May 14, 1999
Molecular characterization of germline mutations in the BRCA1 and BRCA2 genes from breast cancer families in Taiwan
S S Li, H M Tseng, T P Yang, et al.
Annals of Medicine and Surgery (2012)
|
January 3, 2022
A prospective, multicenter trial of a long-term bioabsorbable mesh with Sepra technology in cohort of challenging laparoscopic ventral or incisional hernia repairs (ATLAS trial)
William W Hope, Adel G El-Ghazzawy, Brad A Winterstein, et al.
Interventional Neuroradiology : Journal of Peritherapeutic Neuroradiology, Surgical Procedures and Related Neurosciences
|
March 12, 2013
Taiwan aneurysm registry: multivariate analysis of two-month, one-year, and two-year outcomes after endovascular and microsurgical treatment of ruptured aneurysms
H-M Liu, H-F Wong, K-W Lee, et al.
ESMO Open
|
May 25, 2024
Trastuzumab deruxtecan versus trastuzumab emtansine in HER2-positive metastatic breast cancer patients with brain metastases from the randomized DESTINY-Breast03 trial
S A Hurvitz, S-B Kim, W-P Chung, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 21, 2026
Datopotamab deruxtecan (Dato-DXd) in combination with durvalumab as first-line treatment for unresectable locally advanced or metastatic triple-negative breast cancer: results from arms 7 and 8 of the phase Ib/II BEGONIA study
P Schmid, H-C Wang, F Lynce, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 22, 2020
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with early breast cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS
Y H Park, E Senkus-Konefka, S-A Im, et al.
Blood
|
January 14, 2022
Congenital anemia reveals distinct targeting mechanisms for master transcription factor GATA1
Leif S Ludwig, Caleb A Lareau, Erik L Bao, et al.
ESMO Open
|
May 25, 2024
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with early breast cancer
K H Park, S Loibl, J Sohn, et al.
ESMO Open
|
May 13, 2023
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, staging and treatment of patients with metastatic breast cancer
S-A Im, A Gennari, Y H Park, et al.
Page
of 17